mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |